Article in Sweden's Leading Business Newspaper, Dagens Industri

Dagens Industri (DI) is Sweden's leading business newspaper and media outlet, focusing on finance, economics, and industry-related news. It is widely regarded as a key source of information for business professionals, investors, and decision-makers in Sweden.

Dagens Industri wrote this article about our customer, APL (Apotek Produktion & Laboratorier AB), and its role in supporting the Swedish pharmaceutical industry. Highlights include:

1. APL's Role in Crisis Management: APL, a state-owned pharmaceutical manufacturer, has been critical in addressing drug shortages and ensuring reliable medication supply in Sweden.

2. Focus on Innovation: The company is investing in new, innovative manufacturing methods, such as 3D printing technology, to enhance pharmaceutical production and meet future demands.

3. Leadership Vision: Erik Haeffler, the CEO, emphasizes APL's strong position in the market, with the resources and expertise to explore new areas of innovation and strengthen its role in the pharmaceutical industry.

4. 3D Printing Advancements: A key innovation is the development of individualized medicine using 3D printing. This technology allows for precision manufacturing and personalized drug production, expected to be fully operational by 2025.

5. Safety and Security: APL's efforts also focus on ensuring societal safety by maintaining a robust pharmaceutical supply chain during critical times.

The article highlights APL's commitment to combining innovation with societal impact in the pharmaceutical sector.

Read more: https://www.apl.se/

https://www.di.se/